ILF2 Directly Binds and Stabilizes CREB to Stimulate Malignant Phenotypes of Liver Cancer Cells
Cyclic adenosine monophosphate (cAMP) response element-binding protein (CREB) is overexpressed and has an oncogenic role in hepatocellular carcinoma (HCC). Interleukin enhancer binding factor 2 (ILF2) has become research hotspot in liver cancer recently. However, it is still unclear whether and how...
Main Authors: | Hui Du, Yun Le, Fenyong Sun, Kai Li, Yanfeng Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2019-01-01
|
Series: | Analytical Cellular Pathology |
Online Access: | http://dx.doi.org/10.1155/2019/1575031 |
Similar Items
-
Functional and Structural Studies of the DNA Binding Domain of Interleukin Binding Factor(ILF)
by: Chen, Su-Wuan, et al. -
Metabolomic Characterization Reveals ILF2 and ILF3 Affected Metabolic Adaptions in Esophageal Squamous Cell Carcinoma
by: Bin Zang, et al.
Published: (2021-09-01) -
Expression and Clinical Significance of ILF2 in Gastric Cancer
by: Zi-huan Yin, et al.
Published: (2017-01-01) -
CREB inhibits AP-2alpha expression to regulate the malignant phenotype of melanoma.
by: Vladislava O Melnikova, et al.
Published: (2010-08-01) -
The positive feedback loop between ILF3 and lncRNA ILF3-AS1 promotes melanoma proliferation, migration, and invasion
by: Gao G, et al.
Published: (2018-12-01)